Stay updated on Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial

Sign up to get notified when there's something new on the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updated from v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T16:48:32.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A minor site revision update was added (Revision: v3.4.2) and the prior government funding/status notice was removed (Revision: v3.4.1), with no impact on study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:37:30.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide funding/status notice was added and a PubMed publication reference related to the study was included. These updates do not change the core study content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-04T05:36:27.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary content is now displayed on the page. Metadata labels were updated to show Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T03:21:13.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 added and v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:22:13.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A unified 'Locations' section lists sites in California, New Jersey, and New York; prior 'California Locations', 'New Jersey Locations', and 'New York Locations' sections were removed, and the revision version updated from v3.3.2 to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T17:31:48.000Z thumbnail image

Stay in the know with updates to Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mogamulizumab and Pembrolizumab in DLBCL Clinical Trial page.